The global cancer genetic testing market size was valued at USD 6.70 billion in 2024 and is projected to reach from USD 7.47 billion in 2025 to USD 17.98 billion by 2033, growing at a CAGR of 11.6% during the forecast period (2025-2033).New York, United States, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cancer is the second leading cause of death worldwide, with approximately 70% of cancer deaths occurring in low- and middle-income countries, increasing the demand for genetic testing. Genetic testing can help predic ...